The International Association of Fire Fighters has warned that the growing use of GLP-1 weight loss drugs among firefighters raises important occupational health questions, particularly because no studies have yet examined how the medications or their side effects affect firefighters on the job.
GLP-1 receptor agonists, a class of prescription drugs used for type 2 diabetes and weight loss, can help some patients lose significant body weight by lowering blood sugar and reducing appetite. However, the IAFF said members taking or considering the drugs should speak with a physician before starting or stopping treatment.
The union highlighted several potential concerns for firefighters, including nausea, vomiting, diarrhea and reduced thirst. These side effects can increase the risk of dehydration, which is already a major concern in firefighting because of heat exposure, heavy personal protective equipment and intense physical exertion.
According to the IAFF, dehydration can impair endurance and physical performance and may contribute to heat-related illness, urinary and kidney problems, seizures and other serious complications. The organization said more research is needed to understand whether GLP-1 use creates additional risks for firefighters working in high-heat, strenuous environments.
The IAFF also cautioned that weight loss and fitness are not the same. Some studies suggest that a portion of weight lost while using GLP-1 drugs can include lean body mass, rather than fat alone. The union said firefighters using the medications should maintain exercise routines to protect strength, endurance and operational readiness.
Fire & Safety Journal Americas
The post IAFF: GLP-1 weight loss drugs raise key safety questions for firefighters appeared first on Daily Dispatch.